Yuyu Pharma (000220) — Cash Flow Quality Index
Yuyu Pharma (000220) has a Cash Flow Quality Index of 0.21x as of September 2025. Operating cash flow of ₩836.62 Million is below net income of ₩3.98 Billion, suggesting accrual-heavy earnings not yet converted to cash. Explore how much of Yuyu Pharma's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Yuyu Pharma Cash Flow Quality Index (2011–2024)
Historical Cash Flow Quality Index for Yuyu Pharma across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Yuyu Pharma tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Yuyu Pharma (2011–2024)
Year-by-year earnings quality comparison for Yuyu Pharma. For live market cap and the full company financial profile, see 000220 company net worth.
| Year | Quality Index | Operating CF (KRW) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 2.86x | ₩24.95 Billion | ₩8.72 Billion | ▲ +237.6% |
| 2020 | -2.08x | ₩-2.67 Billion | ₩1.28 Billion | ▼ -174.5% |
| 2019 | 2.79x | ₩13.19 Billion | ₩4.72 Billion | ▲ +83.7% |
| 2018 | 1.52x | ₩6.11 Billion | ₩4.02 Billion | ▲ +1584.3% |
| 2017 | 0.09x | ₩561.35 Million | ₩6.22 Billion | ▼ -94.6% |
| 2016 | 1.67x | ₩9.82 Billion | ₩5.89 Billion | ▲ +450.8% |
| 2013 | -0.48x | ₩-775.17 Million | ₩1.63 Billion | ▼ -120.1% |
| 2012 | 2.36x | ₩6.51 Billion | ₩2.76 Billion | ▼ -47.8% |
| 2011 | 4.52x | ₩6.67 Billion | ₩1.48 Billion | — |